1028 (1028) Fair Value & Analysis

Consumer Cyclical · Market cap HK$1.9B

1 1028 1028 · HK

PriceHK$0.7800

Fair ValueHK$0.3600

Upside-53.8%

Quality64/100

Evidence: Medium Range HK$0.3200 – HK$0.3900

Fair value as of: Jul 2, 2026

From 10 valuation models · updated today

Share price −49.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1880 – HK$1.74 · fair‑value band HK$0.3200 – HK$0.3900 · the HK$0.7800 price screens above the HK$0.3600 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1028 (1028) currently trades at HK$0.7800, while our model-based Fair Value estimate is HK$0.3600 — implying the stock looks roughly 53.8% overvalued today. We read business quality at 64/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1028 generated revenue of HK$1.2B at a net margin of -12.4%. Revenue declined 14.6% year over year. It earns a return on equity of -13.1%. The balance sheet holds a net cash position of HK$538M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.2B

Revenue growth (YoY) -14.6%

Net margin -12.4%

Return on equity -13.1%

Free cash flow HK$119M FY2025

Operating margin -5.2%

More key figures

EPS (TTM) HK$-0.0700

EPS growth (YoY) +15.2%

Net cash HK$538M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1028 reported revenue of HK$1.2B in FY2025 versus HK$1.6B in FY2021, a compound −7.1%/yr. Reported net income was −HK$150M in FY2025.

Revenue −7.1%/yr

FY21 HK$1.6B

FY22 HK$1.4B

FY23 HK$1.5B

FY24 HK$1.4B

FY25 HK$1.2B

Net income

FY21 HK$27.3M

FY22 HK$14.8M

FY23 HK$20.8M

FY24 HK$48.2M

FY25 −HK$150M

Is 1028 fairly valued? → Check now

Similar stocks

6 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
NIKE, Inc NKE	€37.34	€45.62	+22%
adidas AG ADDYY	$99.68	$63.37	-36%
ASICS Corporation ASCCY	$26.56	$19.43	-27%
Deckers Outdoor Corporation DECK	$105.57	$172.88	+64%
On Holding ONON	$38.32	$21.64	-44%
Zhejiang China Commodities City Group 600415	¥10.63	¥18.58	+75%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1028 (1028) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.3600 versus a price of HK$0.7800 — about −54% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1028?

Our model-based fair value for 1028 is HK$0.3600 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.7800.

What is the quality score of 1028?

1028 has a Quality Score of 64/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1028 (1028)?

1028 reported trailing-twelve-month revenue of about HK$1.2B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1028?

The net profit margin of 1028 is about -12.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.